Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
D

Drugs Made In America Acquisition Corp
NASDAQ:DMAA

Watchlist Manager
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
Watchlist
Price: 10.84 USD Market Closed
Market Cap: $263.2m
Write Note Create Alert Ask AI

Bankruptcy Probability

Drugs Made In America Acquisition Corp's probability of bankruptcy is 2.4%, pointing to a small but noticeable default risk. The solvency score is 60/100 — a warning sign of potential financial weakness.

We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.

Moderate
Probability of Bankruptcy

Financial Position

Cash & Short-Term Investments
+
Jun 30, 2026 20.3k
Mar 31, 2026 14.9k
Dec 31, 2025 6.1k
Sep 30, 2025 700
Long-Term Investments
+
Jun 30, 2026 146.8m
Mar 31, 2026 242m
Dec 31, 2025 239.9m
Sep 30, 2025 237.6m
Debt
+
Jun 30, 2026 350k
Mar 31, 2026 100k
Dec 31, 2025 0
Sep 30, 2025 0

Solvency Ratios

Solvency Ratios Comparison
Drugs Made In America Acquisition Corp Competitors

Country Company Market Cap D/E D/A Interest
Coverage 		Altman
Z-Score 		Quick
Ratio 		Current
Ratio 		Cash
Ratio
US
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
263.2m USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
BlackRock Inc
NYSE:BLK
163.4B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
BlackRock New York Municipal Income Trust
NYSE:BNY
103.8B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Essex Property Trust Inc
NYSE:ESS
17.4B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
NL
HAL Trust
AEX:HAL
14.8B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Annaly Capital Management Inc
NYSE:NLY
16B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
AGNC Investment Corp
NASDAQ:AGNC
11.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
BE
Sofina SA
XBRU:SOF
8.7B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
TW
ITEQ Corp
TWSE:6213
179.9B TWD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
HA Sustainable Infrastructure Capital Inc
NYSE:HASI
4.8B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
JP
CyberAgent Inc
TSE:4751
639B JPY
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Continue DMAA Research

Summary
DMAA intrinsic value, competitors valuation, and company profile.
DCF Valuation
DMAA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DMAA stock valuation using valuation multiples.
Wall St Estimates
DMAA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DMAA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Is Drugs Made In America Acquisition Corp at risk of bankruptcy?

Drugs Made In America Acquisition Corp's probability of bankruptcy is 2.4%, pointing to a small but noticeable default risk.

The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Drugs Made In America Acquisition Corp have?

As of the latest report, Drugs Made In America Acquisition Corp has total debt of 350k USD. This includes both short-term (350k USD) and long-term (0 USD) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top
ALPHA SPREAD
Follow us
Join 358,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.